Today: 7 February 2026
Subscribe

Sarepta stock sinks as Elevidys sales miss, flu delays spill into 2026

Sarepta stock sinks as Elevidys sales miss, flu delays spill into 2026

Sarepta Therapeutics shares fell 13% to $20.73 Monday after a preliminary update showed weaker-than-expected fourth-quarter sales for its Duchenne gene therapy, Elevidys. The company reported $110.4 million in Elevidys revenue for the quarter, below Wall Street’s $122 million estimate. Sarepta cited a severe flu season and delayed six patient infusions to 2026. Final results are due in late February.
12 January 2026
·
Abercrombie & Fitch stock slides 17% after outlook trim puts tariffs back on the tape

Abercrombie & Fitch stock slides 17% after outlook trim puts tariffs back on the tape

Abercrombie & Fitch shares fell 17.3% to $103.26 after the company cut its full-year sales growth forecast and lowered its holiday-quarter outlook. The retailer now expects fiscal 2025 net sales growth of at least 6%, down from a prior 6%–7% range, and factored in $90 million in tariff expenses. Investors are watching the ICR Conference this week for further updates on demand and pricing.
12 January 2026
·
Merck (MRK) stock slides as JPMorgan conference tests deal buzz and vaccine risk

Merck (MRK) stock slides as JPMorgan conference tests deal buzz and vaccine risk

Merck shares fell 1.1% to $109.27 Monday amid speculation over a possible $28–32 billion acquisition of Revolution Medicines, though no deal has been finalized. The SPDR S&P Biotech ETF dropped 2.1%. Analysts estimate Revolution’s RAS inhibitor drugs could generate over $10 billion in sales by 2035. Merck also faces a potential $2 billion annual revenue hit after U.S. vaccine schedule changes affecting Gardasil and RotaTeq.
12 January 2026
··
Goldman Sachs stock ticks up as Powell probe threat, rate-cap talk keep banks on edge

Goldman Sachs stock ticks up as Powell probe threat, rate-cap talk keep banks on edge

Goldman Sachs shares rose 0.6% to $944.73 in Monday afternoon trading ahead of fourth-quarter earnings due Jan. 15. Markets weighed Trump’s proposed 10% cap on credit-card interest rates and threats to indict Fed Chair Jerome Powell. Traders are focused on Tuesday’s U.S. CPI report and major bank earnings. Goldman’s chief economist now expects Fed rate cuts in June and September.
12 January 2026
···
Nuvation Bio stock slides nearly 18% as Eisai deal, early IBTROZI sales hit screens

Nuvation Bio stock slides nearly 18% as Eisai deal, early IBTROZI sales hit screens

Nuvation Bio shares fell 17.7% to $6.62 Monday after announcing a licensing deal with Eisai and releasing initial sales data for its lung-cancer drug. Eisai will pay €50 million upfront for rights outside the U.S., China, and Japan, with further milestone payments possible. Fourth-quarter Ibtrozi sales met estimates, but investors appeared cautious on future prescription growth.
12 January 2026
····
Mastercard stock drops as Trump’s 10% credit-card rate cap plan rattles card-linked names

Mastercard stock drops as Trump’s 10% credit-card rate cap plan rattles card-linked names

Mastercard shares fell 1.7% to $565.93 Monday after President Trump called for a one-year 10% cap on credit card interest rates, sending card stocks lower. Visa dropped 1.7% and American Express slid 4.2%. Analysts said such a cap would need Congressional approval and warned it could hurt lender profits. Separately, Google named Mastercard as an endorser of its new Universal Commerce Protocol for AI-driven shopping.
12 January 2026
·
Why Johnson & Johnson stock is up today: new Rybrevant data and earnings ahead

Why Johnson & Johnson stock is up today: new Rybrevant data and earnings ahead

Johnson & Johnson shares rose 2.3% to $209.03 after new data showed its drug Rybrevant, combined with chemotherapy, produced a 51% response rate in metastatic colorectal cancer. The results, from the OrigAMI-1 trial, included a 73% response rate in first-line patients. The company’s fourth-quarter earnings report is due Jan. 21. J&J recently struck a deal with the Trump administration to lower U.S. drug prices.
12 January 2026
···
Reddit stock (RDDT) slips as insider selling hits the tape; CPI report is the next test

Reddit stock (RDDT) slips as insider selling hits the tape; CPI report is the next test

Reddit shares fell 1.1% to $241.85 Monday as the S&P 500 and Nasdaq-100 ETFs edged up 0.2%. Wells Fargo raised its price target to $207 but kept an equal-weight rating. SEC filings showed Reddit’s chief legal officer and CFO sold shares under preset trading plans. Daily active users rose 19% to 116 million, with revenue up 68% to $585 million.
12 January 2026
········
First Majestic Silver stock jumps 7% as silver rips to a fresh record — what investors watch next

First Majestic Silver stock jumps 7% as silver rips to a fresh record — what investors watch next

First Majestic Silver shares jumped 7% to $20.24 Monday as silver surged 6.8% to $85.39 an ounce, drawing heavy trading volume. Peer miners also rallied, with Hecla Mining up nearly 9%. Investors await Tuesday’s U.S. inflation data, which could shift rate and metals forecasts. JPMorgan and other banks have delayed expectations for Fed rate cuts into 2026 or later.
12 January 2026
·
Sibanye Stillwater stock jumps as gold cracks $4,600, putting Jan. 29 strategy update in play

Sibanye Stillwater stock jumps as gold cracks $4,600, putting Jan. 29 strategy update in play

Sibanye Stillwater’s U.S. shares surged 7.3% to $16.79 Monday afternoon as gold broke above $4,600 an ounce, driven by renewed U.S. policy uncertainty. The miner announced a strategy update for Jan. 29, giving investors a new short-term focus. Other gold stocks, including Harmony Gold and Gold Fields, also posted sharp gains. Traders are watching the Federal Reserve’s Jan. 27-28 meeting for signals on rates.
12 January 2026
··
Nebius (NBIS) stock jumps on report of 800MW Kansas City-area data center plan

Nebius (NBIS) stock jumps on report of 800MW Kansas City-area data center plan

Nebius shares jumped 10.2% to $107.87 Monday after reports of an 800-megawatt AI data center campus planned near Kansas City. The $6.6 billion project, proposed for Independence, Missouri, would span up to 10 buildings and 400 acres, with construction expected to start in early 2026. Investors are watching local approvals and the pace of power infrastructure development.
12 January 2026
··
Procter & Gamble stock rises as defensive staples rally on Powell probe; PG earnings ahead

Procter & Gamble stock rises as defensive staples rally on Powell probe; PG earnings ahead

Procter & Gamble shares rose about 1% to $143.29 Monday afternoon, outpacing the S&P 500’s 0.2% gain as consumer-staples stocks advanced. The move came amid renewed market volatility after news broke of a criminal probe into Fed Chair Jerome Powell. Investors are watching U.S. inflation data and P&G’s Jan. 22 earnings report for further direction.
12 January 2026
··
Pure Storage stock jumps nearly 8% as investor focus turns to insider filing, CPI and a Needham webcast

Pure Storage stock jumps nearly 8% as investor focus turns to insider filing, CPI and a Needham webcast

Pure Storage shares rose 7.9% to $72.29 on Monday, outpacing the broader market. A Friday filing showed founder John Colgrove transferred 200,000 shares as gifts between family trusts. Investors are watching Tuesday’s U.S. CPI report and Pure’s presentation at the Needham Growth Conference on Thursday. Peer stocks, including NetApp and Western Digital, also advanced.
12 January 2026
···
Gold Fields stock jumps as gold breaks $4,600; CPI and earnings in focus

Gold Fields stock jumps as gold breaks $4,600; CPI and earnings in focus

Gold Fields shares surged 6.7% to $48.73 in New York Monday after gold prices hit a record high, prompting gains across gold miners. The rally followed safe-haven buying and a weaker dollar ahead of Tuesday’s U.S. inflation report. Gold Fields earlier touched $49.58, with Newmont, AngloGold Ashanti, and Wheaton Precious Metals also advancing. Investors await CPI data for clues on rates and sector momentum.
12 January 2026
·······
1 … 436 437 438 439 440 … 1,636

Stock Market Today

Linde stock price falls as LIN heads into weekend; JPMorgan downgrade and guidance in focus

Linde stock price falls as LIN heads into weekend; JPMorgan downgrade and guidance in focus

7 February 2026
Linde plc shares fell 2.5% to $448.24 Friday after reporting Q4 sales up 6% to $8.76 billion and adjusted EPS of $4.20. The company guided 2026 adjusted EPS to $17.40–$17.90, below analyst consensus. JPMorgan downgraded the stock, while Morgan Stanley and UBS raised price targets. Linde repurchased $1.4 billion in shares in Q4 and returned $7.4 billion to shareholders in 2025.
GE Vernova stock closes up nearly 6% — what to watch before Monday’s trade

GE Vernova stock closes up nearly 6% — what to watch before Monday’s trade

7 February 2026
GE Vernova shares jumped 5.6% to $779.35 Friday as Wall Street rallied and the company reported 1.1 GW of U.S. wind repower orders for 2025. The company also closed its $5.3 billion purchase of the remaining Prolec GE stake and completed a $2.6 billion senior notes offering. Investors await next week’s U.S. jobs and inflation data.
Go toTop